Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Int J Gynecol Cancer. 2015 Nov;25(9):1587–1592. doi: 10.1097/IGC.0000000000000540

TABLE 2.

Ovarian cancer survival by reproductive characteristics

Characteristic Survival, Median (Range), mo Crude HR (95% CI)* aHR (95% CI)*
Age at menarche, y
  <12 56 (1–30) Reference Reference
  12 52 (8–371) 0.98 (0.70–1.37) 1.04 (0.74–1.47)
  13 50 (2–359) 0.86 (0.62–1.21) 1.01 (0.72–1.43)
  ≥14 67 (3–386) 0.77 (0.55–1.09) 0.95 (0.67–1.35)
Menstrual regularity
  Regular 56 (1–386) Reference Reference
  Irregular 72 (3–346) 0.77 (0.54–1.10) 0.99 (0.69–1.42)
Ever used OCs
  No 46 (1–386) Reference Reference
  Yes 81 (3–375) 0.51 (0.39–0.66) 0.71 (0.53–0.97)
Ever pregnant
  No 60 (7–386) Reference Reference
  Yes 56 (1–375) 1.15 (0.87–1.51) 0.76 (0.57–1.01)
Ever live birth
  No 60 (7–386) Reference Reference
  Yes 56 (1–375) 1.13 (0.86–1.47) 0.80 (0.60–1.06)
No. births
  None 60 (7–386) Reference Reference
  1 89 (11–375) 0.83 (0.56–1.24) 0.72 (0.48–1.08)
  2 60 (3–341) 1.05 (0.75–1.47) 0.78 (0.55–1.11)
  3 44 (2–335) 1.30 (0.93–1.83) 0.88 (0.62–1.26)
  4+ 41 (1–371) 1.29 (0.93–1.80) 0.81 (0.57–1.14)
Ever had tubal ligation
  No 68 (1–375) Reference Reference
  Yes 56 (3–386) 0.64 (0.43–0.93) 0.90 (0.60–1.34)
Lifetime duration of breastfeeding
  None 61 (1–386) Reference Reference
  <1 y 50 (2–339) 1.31 (1.00–1.70) 1.00 (0.76–1.32)
  1–2 y 76 (8–341) 0.75 (0.47–1.19) 0.68 (0.43–1.08)
  ≥2 y 29 (8–297) 1.48 (0.89–2.47) 0.92 (0.54–1.58)
*

HRs and 95% CIs computed using Cox proportional hazards models.

Adjusted for FIGO stage, age at diagnosis, and histology.